These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20582865)

  • 1. Vaccine Manufacturing--Second Annual visiongain Conference.
    McPherson C
    IDrugs; 2010 Jul; 13(7):437-9. PubMed ID: 20582865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress.
    Sovran L
    IDrugs; 2009 Dec; 12(12):738-41. PubMed ID: 19943212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terrapinn's world influenza congress Europe 2009. Part 2.
    Veryard C
    IDrugs; 2010 Feb; 13(2):78-9. PubMed ID: 20127556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1N1 Swine Flu: The 2010 Perspective--A New York Academy of Sciences Meeting.
    Minieri Arroyo J
    IDrugs; 2010 Jul; 13(7):448-52. PubMed ID: 20582868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
    Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
    Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terrapinn's world influenza congress Europe 2009. Part 1.
    Veryard C
    IDrugs; 2010 Feb; 13(2):76-7. PubMed ID: 20127555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferrets and the challenges of H5N1 vaccine formulation.
    Hampson AW
    J Infect Dis; 2006 Jul; 194(2):143-5. PubMed ID: 16779718
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza Research & Development - GTCBio's Third Annual Conference (July 9-11 - Boston, Massachusetts, USA, 2014).
    Tompkins SM
    Drugs Today (Barc); 2014 Aug; 50(8):599-605. PubMed ID: 25187909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Based Vaccines: Optimising Development and Delivery - A marcus evans Conference.
    Garren H
    IDrugs; 2010 Nov; 13(11):759-61. PubMed ID: 21046520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccine provides priming for A/H1N1 immunization.
    Del Giudice G; Stittelaar KJ; van Amerongen G; Simon J; Osterhaus AD; Stöhr K; Rappuoli R
    Sci Transl Med; 2009 Dec; 1(12):12re1. PubMed ID: 20371459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Shen Z; Bowen RA; Ge P; Yu J; Shen Y; Kong W; Jiang C; Wu J; Zhu C; Xu Y; Wei W; Rudenko L; Kiseleva I; Xu F
    Vaccine; 2016 Nov; 34(48):5953-5958. PubMed ID: 27997342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge.
    Cox F; Roos A; Hafkemeijer N; Baart M; Tolboom J; Dekking L; Stittelaar K; Goudsmit J; Radošević K; Saeland E
    PLoS One; 2015; 10(9):e0135723. PubMed ID: 26402787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BirdFlu2009: Avian Influenza and Human Health. 9-10 September 2009, Oxford, UK.
    Temperton N
    IDrugs; 2009 Nov; 12(11):686-8. PubMed ID: 19844852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models for the preclinical evaluation of candidate influenza vaccines.
    Bodewes R; Rimmelzwaan GF; Osterhaus AD
    Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FluBlok, a recombinant influenza vaccine.
    Huber VC; McCullers JA
    Curr Opin Mol Ther; 2008 Feb; 10(1):75-85. PubMed ID: 18228185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.